Your browser doesn't support javascript.
loading
Non-cell-autonomous cancer progression from chromosomal instability.
Li, Jun; Hubisz, Melissa J; Earlie, Ethan M; Duran, Mercedes A; Hong, Christy; Varela, Austin A; Lettera, Emanuele; Deyell, Matthew; Tavora, Bernardo; Havel, Jonathan J; Phyu, Su M; Amin, Amit Dipak; Budre, Karolina; Kamiya, Erina; Cavallo, Julie-Ann; Garris, Christopher; Powell, Simon; Reis-Filho, Jorge S; Wen, Hannah; Bettigole, Sarah; Khan, Atif J; Izar, Benjamin; Parkes, Eileen E; Laughney, Ashley M; Bakhoum, Samuel F.
Afiliação
  • Li J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hubisz MJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Earlie EM; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.
  • Duran MA; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Hong C; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Varela AA; Bioinformatics Facility, Institute of Biotechnology, Cornell University, Ithaca, NY, USA.
  • Lettera E; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.
  • Deyell M; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Tavora B; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Havel JJ; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Phyu SM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Amin AD; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Budre K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kamiya E; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.
  • Cavallo JA; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Garris C; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Powell S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Reis-Filho JS; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wen H; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.
  • Bettigole S; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Khan AJ; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Izar B; Volastra Therapeutics Inc., New York, NY, USA.
  • Parkes EE; Volastra Therapeutics Inc., New York, NY, USA.
  • Laughney AM; Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, UK.
  • Bakhoum SF; Columbia Center for Translational Immunology, New York, NY, USA.
Nature ; 620(7976): 1080-1088, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37612508

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Instabilidade Cromossômica / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Instabilidade Cromossômica / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article